Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN107056854B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel stable glycosylation donor technology enabling mild conditions and orthogonal protection for high-purity pharmaceutical intermediates manufacturing.